16526-56-0Relevant articles and documents
Convenient Method for the Synthesis of C-Alkylated Purine Nucleosides: Palladium-Catalyzed Cross-Coupling Reaction of Halogenopurine Nucleosides with Trialkylaluminums
Hirota, Kosaku,Kitade, Yukio,Kanbe, Yoshitake,Maki, Yoshifumi
, p. 5268 - 5270 (1992)
-
Isolation and characterization of 2-methyladenosine from Escherichia coli tRNA Glu 2 , tRNA Asp 1 , tRNA His 1 and tRNA Arg .
Saneyoshi,Oashi,Harada,Nishimura
, p. 1 - 10 (1972)
-
Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT)
Hirth, Bradford,Barker Jr., Robert H.,Celatka, Cassandra A.,Klinger, Jeffrey D.,Liu, Hanlan,Nare, Bakela,Nijjar, Amarjit,Phillips, Margaret A.,Sybertz, Edmund,Willert, Erin K.,Xiang, Yibin
scheme or table, p. 2916 - 2919 (2010/02/28)
Modification of the structure of trypanosomal AdoMetDC inhibitor 1 (MDL73811) resulted in the identification of a new inhibitor 7a, which features a methyl substituent at the 8-position. Compound 7a exhibits improved potencies against both the trypanosomal AdoMetDC enzyme and parasites, and better blood brain barrier penetration than 1.
Antiviral Activity of C-Alkylated Purine Nucleosides Obtained by Cross-Coupling with Tetraalkyltin Reagents
Aerschot, Arthur A. Van,Mamos, Petros,Weyns, Nancy J.,Ikeda, Satoru,Clercq, Erik De,Herdewijn, Piet A.
, p. 2938 - 2942 (2007/10/02)
2-, 6-, And 8-alkylated (methyl, ethyl, and vinyl) adenosine analogues were synthesized by a palladium-catalyzed cross-coupling of a tetraalkyltin with the halogenated purine nucleosides.The synthesis of the 8-substituted analogues was accomplished using a transient protection procedure.The 6-alkylated-9-β-D-ribofuranosylpurines as well as 2-ethyladenosine were cytotoxic at relatively low concentrations (0.8-10 μg/mL). 8-Methyladenosine was a potent and selective inhibitor of vaccinia virus, whereas 8-ethyl- and 8-vinyladenosine were specifically inhibitory to respiratory syncytial virus. 8-Vinyladenosine displayed particular activity against herpes simplex virus (type 1).